Drug Profile
Desmopressin transdermal - Zosano Pharma
Latest Information Update: 31 Oct 2021
Price :
$50
*
At a glance
- Originator ALZA Corporation
- Class Antidiuretics; Antihaemorrhagics; Hormones; Peptides; Urologics; Vasoconstrictors; Vasopressins
- Mechanism of Action Vasopressin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Enuresis
Most Recent Events
- 26 Sep 2016 Chemical structure information added
- 01 Sep 2016 Discontinued - Phase-I for Enuresis (Transdermal)
- 29 Sep 2015 Phase-I clinical trials in Enuresis (Transdermal)